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Abstract
Uncontrolled diabetics are prone to infections due to numerous factors as the glucose-rich blood
serves as an excellent media for growth. Cryptococcus neoformans is an opportunistic fungus that
is an important cause of CNS infections among immunocompromised patients, but it has only
sporadically been reported in non-HIV-positive persons. The presence of elevated pro-
inflammatory cytokines and abnormalities in numerous systemic indicators of inflammation in
diabetics makes it conceivable that diabetics mount an exaggerated immune response to C.
neoformans (paradoxical to their defective immune state) leading to grave outcomes. We present
a fatal case of C. neoformans meningitis in a diabetic patient which emphasizes the perils of an
overzealous immune response.
Case presentation
A 72-year-old Caucasian male of Italian-American descent
was admitted for unremitting, severe, right frontal head-
ache, gait ataxia, and slurred speech for the preceding five
days. His past medical history was notable for insulin-
dependent diabetes, hypertension, and mitral valve
replacement. Social history was unremarkable; he was a
retired shipyard laborer. The patient's wife denied recent
travel or pets.
The history goes back ten days prior to presentation when
the patient was evaluated at an outside institution for per-
sistent headaches and gait ataxia. At that time, computed
tomography of the head was negative for an acute bleed or
mass. The patient was presumed to have metabolic
encephalopathy and was admitted to the rehabilitation
ward for further evaluation of the gait disturbance. He was
transferred back to the medical ward for change in mental
status and worsening encephalopathy.
Initial vital signs were notable for a maximum tempera-
ture of 101.2°F, BP 120/70 mmHg, pulse 78 beats/min.,
respiratory rate 20 breaths/min. Physical examination
revealed a lethargic man, but who was arousable to verbal
and tactile stimuli; he moved all extremities. Reflexes were
intact and he followed simple commands. The remainder
of the physical exam was normal.
Admission labs were notable for glucose of 225 mg/dL,
creatinine of 1.4 mg/dL, ammonia level of 58 umol/L, and
WBC count 14.3 × 103cells/mm3 (81% neutrophils, 10%
lymphocytes). Other routine labs were unremarkable. The
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urinalysis showed moderate bacteruria and blood with
12-20 WBCs/hpf.
Computed tomography of the head, chest radiograph,
and EKG were unremarkable. Renal ultrasound revealed
normal kidneys with no evidence for hydronephrosis.
Blood and urine cultures were drawn; the patient was
started on intravenous ciprofloxacin, and was admitted
for change in mental status secondary to urosepsis.
Over the next 48 hours, the patient began spiking fever
above 101°F and became non-verbal. A lumbar puncture
was conducted and revealed clear, colorless CSF, with 150
WBC/mm3 (95% lymphocytes, 5% neutrophils), 0 RBC/
mm3, protein 158 mg/dL, glucose 73 mg/dL (serum level,
380), chloride 121 mEq/L. Opening pressure of the CSF
was not measured. The CSF gram stain showed the pres-
ence of budding yeast and India ink stain was positive
(See figure 1). The patient was started on intravenous
amphotercin B and flucytosine.
Over the next few days, the patient became more respon-
sive and mild improvement in mental status was noted.
However, there was no improvement in his speech. Dur-
ing this time, his serum glucose remained elevated, rang-
ing between 274 mg/dL to 364 mg/dL. The amphotericin
B was changed to a liposomal formulation because of
renal insufficiency. Subsequent CSF cytology revealed
organisms consistent with Cryptococcus neoformans. The
CSF culture was also positive for C. neoformans. The CSF
cryptococcal antigen titer using latex particle agglutina-
tion was over 1:1024. Further testing for Lyme antibodies
and HIV antibodies was negative. An echocardiogram
revealed normal left ventricular size and function with no
vegetations. Blood and urine cultures were negative. The
antifungals were continued.
By hospital day 10, the patient became more arousable to
verbal and tactile stimuli and would answer simple ques-
tions. However, he remained lethargic and febrile. The
WBC count remained elevated at 13.9 × 103/mm3, with
89% granulocytes. The serum glucose was 263 mg/dL and
continued to be uncontrolled. A repeat CT head showed
the new development of moderately enlarged third and
lateral ventricles consistent with mild communicating
hydrocephalus. A repeat lumbar puncture was recom-
mended to assess the CSF opening pressure. While the LP
was being attempted, the patient became cyanotic and
unresponsive. The patient was emergently intubated and
advanced cardiac life support was started. The initial car-
diac rhythm was asystole, which with ACLS became a
wide complex bradycardia, then subsequently ventricular
fibrillation and finally refractory asystole. Despite aggres-
sive attempts at resuscitation, the patient expired.
An autopsy was conducted. The CNS examination
revealed findings consistent with cryptococcal meningitis
affecting the basal leptomeninges, which were opaque
and thickened. Furthermore, there was reactive connective
tissue obstructing the outflow of CSF consistent with
hydrocephalus. There was marked cerebral edema with
uncal grooving and midbrain compression. Sections of
the brain showed numerous areas of tissue destruction
and gelatinous, mucoid material within the subarachnoid
space. The meningeal exudate consisted of chronic
inflammatory cells along with cryptococci. Some sections
of the brain also disclosed macrophages and multinucle-
ated giant cells indicating granulomatous inflammation.
The cause of death was herniation of the cerebellar tonsils
through the foramen magnum with subsequent impac-
tion and acute compression of the medulla oblongata
causing respiratory and circulatory arrest. There was no
evidence of acute myocardial infarction or pulmonary
embolism.
Discussion
Cryptococcus neoformans is an opportunistic fungus that is
an important cause of CNS infections among immuno-
compromised patients, but it has only sporadically been
reported in non-HIV-positive persons. The most common
forms of immunosuppression (other than HIV) include
chronic glucocorticoid use, history of organ transplanta-
tion, malignancy, as well as sarcoidosis and liver failure.
During a 17-year, retrospective review study of non-HIV
patients with cryptococcal infection, Kiertiburanakul et al
showed that the most common associated conditions
included immunosuppressive drug treatment (41%),
India ink preparation of cerebrospinal fluid from a patient  with cryptococcal meningitis showing the budding yeast cells  of C. neoformans surrounded by a characteristic wide gelati- nous capsule Figure 1
India ink preparation of cerebrospinal fluid from a 
patient with cryptococcal meningitis showing the 
budding yeast cells of C. neoformans surrounded by a 
characteristic wide gelatinous capsule. The yeasts also 
show narrow-base budding and characteristic variation in 
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presence of systemic lupus erythematosus (16%), malig-
nancies (16%), and diabetes mellitus (14%) [1]. Our case
represents this small, but significant, fraction of diabetic
patients.
Cryptococcus neoformans produces infection following
inhalation through the respiratory tract. The organism
then disseminates hematogenously and has a propensity
to infect the CNS (neurotropism). This predilection has
been postulated to be due to several factors: the high level
of dopamine in the CNS potentially serves as a reservoir
of melanin production which may increase fungal viru-
lence [2]; the CSF provides a rich medium to promote fun-
gal growth; and the local production of mannitol by the
fungus may contribute to cerebral edema and interfere
with phagocyte function [3].
Our patient was diabetic and succumbed to CNS crypto-
coccosis. During the hospitalization, his blood sugar was
consistently elevated. Uncontrolled diabetics are much
more prone to infections due to numerous factors as the
glucose-rich blood serves as an excellent media for growth
and when infections do occur, they are more serious. Dia-
betic ketoacidosis, for example, is caused by or compli-
cated by an infection in many cases. Some of the
commonly seen infections seen in diabetics, including
rhinocerebral mucormycosis, malignant otitis externa,
emphysematous cholecystitis/pyelonephritis, and acute
necrotizing fasciitis reflect defects of the immune system.
Hyperglycemia is known to cause impaired polymorpho-
nuclear chemotaxis, abnormal phagocytosis, and defi-
cient cell-mediated immunity. The most important host
response to cryptococcal infection is most probably cell-
mediated immunity as the effector cells against the yeast
include CD4+ and CD8+ lymphocytes, natural killer cells,
and activated phagocytes that produce granulomatous
inflammation [4]. Granuloma formation also requires the
presence of TNF, IL-2, IL-12, and inflammatory cytokines,
such as monocyte chemotactic protein-1(MCP-1), and
macrophage inflammatory protein-α (MIP-α), which col-
lectively are involved in recruiting host cells to the site of
infection leading to inflammation [5]. Since serum levels
of MCP-1 are elevated in patients with type 2 diabetes [6],
as are levels of TNF-α and interleukin-6 [7], it is conceiva-
ble that diabetics mount an exaggerated immune response
to C. neoformans (paradoxical to their defective immune
state) leading to fatal outcomes. Furthermore, subclinical
systemic inflammation and abnormalities in numerous
systemic indicators of inflammation have been reported
in type 2 diabetics. Increased resting systemic inflamma-
tion and elevated basal cytokine formation may in part be
due to advanced glycation end products (AGEs). An
increased formation of AGEs occurs in poorly controlled
diabetics, which could play a role in increased basal
cytokine production [8].
This suggests that anti-inflammatory measures may have
an adjunctive role in the therapy of cryptococcal meningi-
tis in diabetic patients. Corticosteroids decrease vascular
permeability, inhibit leukocyte migration to sites of
inflammation, and intracellularly block the transcription
of pro-inflammatory proteins. Using anti-inflammatory
medications to help treat infectious diseases has been
described. For patients with pneumococcal meningitis,
tuberculous meningitis, tuberculous pericarditis, severe
typhoid fever, tetanus, or pneumocystis pneumonia with
moderate to severe hypoxemia, treatment with corticos-
teroids has been shown to improve survival [9]. Though it
remains controversial, case reports have been described
regarding the beneficial use of corticosteroids in non-HIV
patients with cryptococcal meningitis [10].
In conclusion, our case of overwhelming cryptococcal
meningitis in a diabetic patient demonstrates the perils of
an intense inflammatory response, which may play a cru-
cial role in the pathogenesis of CNS cryptococcal disease
in this patient population. The implications of this case
are noteworthy. Cryptococcal meningitis should be con-
sidered in the differential diagnosis for all persons, includ-
ing non-HIV patients, who present with chronic
headache, especially if there is also the presence of fever,
neurologic deficits, or neuroradiologic findings. The neu-
rotropic property of C. neoformans and its numerous viru-
lence factors add to its lethality. Diabetic patients are at
increased risk for infections due to numerous defects in
their immune system and immune response. Uncon-
trolled hyperglycemia has been shown to cause alterations
in host defense and, thereby, increased susceptibility to
infections. Pro-inflammatory cytokines, such as TNF-α
and various interleukins, are elevated in hyperglycemic
states and are significantly lowered by insulin therapy.
Since immune cell dysfunction and desynchronized
inflammatory cytokines may be partially responsible for
the greater risk of infection and the corresponding high
morbidity and mortality in diabetic patients, agents capa-
ble of altering host cell function (i.e., exogenous anti-
cytokine therapy), potentially hold an attractive therapeu-
tic modality to supplement current antimicrobial agents
in the future.
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